TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
NAUT

Nautilus Biotechnology Inc

Healthcare · Biotechnology

1.60$ +10.6% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Nautilus Biotechnology Inc (NAUT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 164 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NAUT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
318 306 289 273 260 243 228 213 201 191 178 164
187 177 185 171 144 133 142 151 134 106 99 88
74 19 26 25 4.4 28 33 34 24 12 15 13
183 173 181 167 141 130 139 148 131 103 96 84
41 40 39 37 36 34 33 32 32 34 33 32
8.9 9.1 9.2 8.7 8.7 7.6 8.2 8.1 9.0 8.0 8.3 8.6
3.5 3.5 3.7 3.8 4.0 4.1 4.2 4.2 4.2 3.8 3.9 4.0
1.1 1.6 1.9 1.6 1.5 1.0 0.8 1.0 0.9 0.9 1.2 1.1
277 265 249 235 223 209 194 181 169 157 144 131
-185 -202 -221 -239 -255 -273 -290 -305 -318 -332 -347 -361
125 125 125 125 125 126 126 126 126 126 127 127

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?